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The  chemical  component  and  biological  activity  of  propolis  depend  on ﬂora area  of  bee  collection  and
bee  species.  In  the  study, the  propolis  from  three  stingless  bee  species,  Lepidotrigona  ventralis  Smith,
Lepidotrigona  terminata  Smith,  and Tetragonula  pagdeni  Schwarz,  was  collected  in  the  same  region  of
mangosteen  garden  from  Thailand.  Total  phenolic  content,  alpha  glucosidase  inhibitory  effect,  and  free-
radical scavenging  activity  using  FRAP,  ABTS,  DPPH  assays  were  determined.  The  most  potent  activity  of
propolis  extract  was  investigated  for  bioactive  compounds  and  their  quantity.  The  ethanol  extract  of  T.
pagdeni propolis  had  the  highest  total  phenolic  content  12.83  ± 0.72  g  of  gallic  acid equivalents  in 100  g
of  the  extract,  and  the strongest  alpha  glucosidase  inhibitory  effect  with  the  IC50 of  70.79  ±  6.44  g/ml.
The  free-radical  scavenging  activity  evaluated  by  FRAP,  ABTS,  DPPH  assays  showed  the  FRAP  value  of
279.70  ± 20.55  mol  FeSO4 equivalent/g  extract and  the  IC50 of  59.52  ± 10.76  and  122.71 ± 11.76 g/ml,
respectively.  Gamma-  and  alpha-mangostin  from  T. pagdeni  propolis  extract  were  isolated  and  deter-
mined  for  the biological  activity.  Gamma-mangostin  exhibited  the  strongest  activity  for  both  alpha
glucosidase  inhibitory  effect  and  free-radical  scavenging  activity.  Using  HPLC  quantitative  analysis
method,  the content  of gamma-  and  alpha-mangostin  in  the extract  was  found to  be  0.94  ± 0.01  and
2.77  ± 0.08%  (w/w),  respectively.  These  ﬁndings  suggested  that  T. pagdeni  propolis  may  be used  as a more
suitable  raw  material  for  nutraceutical  and pharmaceutical  products  and these  mangostin  derivatives  as
markers.
© 2015 Sociedade  Brasileira  de  Farmacognosia.  Published  by Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
Overproduction of free radical species can be damaging to host
ells and lead to various ailments such as inﬂammatory, aging and
iabetes (Zhou et al., 2015). In the case of diabetes, alpha glucosi-
ase is a vital enzyme essential for cleavage of maltose to glucose
or the absorption into the blood stream in the small intestine.
herefore, alpha glucosidase inhibitors could regulate abnormally
igh stages of plasma glucose after carbohydrate ingestion (Ryu
t al., 2011). Nowadays, -glucosidase inhibitors, such as acarbose,
oglibose and miglitol, have been accepted for clinical use in
he treatment of type 2 diabetes. Nonetheless, some synthetic
lpha glucosidase inhibitors have undesirable side effects, such
s abdominal cramping, ﬂatulence and diarrhea (Zhang et al.,
015). As a result, many scientists have turned their attention to
∗ Corresponding author.
E-mail: boonyadist@buu.ac.th (B. Vongsak).
http://dx.doi.org/10.1016/j.bjp.2015.07.004
102-695X/© 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editoranatural alpha glucosidase inhibitors including mangosteen and
bee products, which are utilized to develop nutraceuticals or lead
compounds for antidiabetic management (Matsui et al., 2004; Ryu
et al., 2011; Juárez-Rojop et al., 2014).
Natural products from bees have been extensively employed
since ancient time because of its broad pharmacological activity
(Dantas et al., 2014; Kustiawan et al., 2014). Propolis is one of
the bee products that exhibits numerous biological activities such
as antioxidant, anti-inﬂammatory, antitumor, antiviral, antibac-
terial, antifungal, antidiabetic activities and is also listed in the
London Pharmacopoeias and Chinese Pharmacopoeias (Sforcin and
Bankova, 2011; Zhang et al., 2015). However, the chemical and bio-
logical activities of propolis vary depending on bee species and the
ﬂora at site of bee collection. For instance, propolis from Europe
and North America regions’ main compounds comprises mostly ﬂa-
vanones, ﬂavones, cinnamic acids and their esters, while that from
Brazil comprises mainly prenylated p-coumaric acids, diterpenic
acids (Bankova, 2005; Sforcin, 2007). Also, different races of hon-
eybees collected at the same area demonstrated varying potency.
 Ltda. All rights reserved.
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pis mellifera caucasica showed a superior antibacterial activity to
pis mellifera carnica and Apis mellifera anatolica; stingless bees –
rigona incisa, Timia apicalis, Trigona fusco-balteata and Trigona fus-
ibasis – from Indonesia revealed different degrees of cytotoxicity
Silici and Kutluca, 2005; Kustiawan et al., 2014).
Stingless bees, whose propolis is utilized for medicinal and
utraceutical purposes, are a large group of eusocial insect that play
 part in plant pollination in tropical regions (Choudhari et al., 2012;
a Cunha et al., 2013). In Thailand and India, stingless bee propo-
is is popularly applied for the treatment of maladies such as acne,
iabetes and inﬂammation (Umthong et al., 2011; Choudhari et al.,
012). Antimicrobial, antiproliferative and antioxidant activities of
everal species of stingless bee propolis were also investigated (da
unha et al., 2013; Dutra et al., 2014). Nevertheless, the study of
ropolis from Thai stingless bees, (Lepidotrigona ventralis Smith,
epidotrigona terminata Smith, and Tetragonula pagdeni Schwarz
Apidae)), which are commercially cultivated in artiﬁcial hives in
ruit gardens and marketed in several preparations in Thailand,
s limited. Thus, the objective of the present work was  to com-
are alpha glucosidase inhibitory effect and free-radical scavenging
ctivity of propolis from three stingless bee species in the same
rea of Thai mangosteen orchard. The active compounds from the
pecies that demonstrated the strongest activity were identiﬁed
nd quantiﬁed.
aterials and methods
hemical products
1,1-Diphenyl-2-picrylhydrazyl (DPPH) radical, 2,2′-azino-bis-
3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS),
,4,6-Tris(2-pyridyl)-s-triazine (TPTZ), -glucosidase from Saccha-
omyces cerevisiae,  acarbose, 4-nitrophenyl -d-glucopyranoside
pNPG), iron(III)chloride hexahydrate, ferrous sulfate, iron(II)
ulfate heptahydrate, were obtained from Sigma–Aldrich® (St.
ouis, MO,  USA), aluminum chloride, acetic acid, ascorbic acid,
olin–Ciocalteu reagent, gallic acid were purchased from Merck®
Darmstadt, Germany). Sodium bicarbonate and potassium per-
ulfate were purchased from Ajax Finechem® (NSW, Australia).
ll reagents were of analytical grade. Deionized water was puri-
ed by Ultra ClearTM system (Siemen Water Technologies Corp®).
thanol, ethyl acetate, dichloromethane, hexane, formic acid and
PLC grade methanol were purchased from Labscan® (Thailand).
tandard gamma-mangostin (1) and alpha-mangostin (2) purity
ore than 98% were purchased from Chengdu Biopurify Phyto-
hemicals Ltd, Sichuan, China.
ropolis sample and preparation
Propolis of Lepidotrigona ventralis Smith, Lepidotrigona terminata
mith, and Tetragonula pagdeni Schwarz were collected from an
piary in the mangosteen garden in December from Makham dis-
rict, Chanthaburi province, eastern of Thailand in 2014, and kept
n the dark at 4 ◦C until use. The stingless bees were identiﬁed by
r. Chama Inson, Department of Entomology, Faculty of Agricul-
ure, Kasetsart University. The voucher specimens (Lepidotrigona
entralis No. 1214001, Lepidotrigona terminata No. 1214003, and
etragonula pagdeni No. 1214003) were deposited at Faculty of
harmaceutical Sciences, Burapha University, Thailand.
Propolis from different bee species (10 g) was separately cleaned
nd cut into small pieces and was then sonicated with 80% ethyl
lcohol (200 ml)  at 40 ◦C for 30 min. The suspension was cen-
rifuged at 3000 × g for 5 min  at 20 ◦C. The supernatant was kept
hile the pellet was re-extracted using the same procedure. The
upernatants were pooled together and evaporated in a rotaryrmacognosia 25 (2015) 445–450
evaporator. Each extract was  dewaxed by sonication with 100 ml  of
hexane at 40 ◦C for 20 min  and centrifuged at 2000 × g for 5 min  at
20 ◦C. The supernatant was  discarded while the crude residue was
kept and stored in the dark at 0 ◦C.
Separation of active compounds
The propolis extract that exhibited the strongest activity was
selected to separate the bioactive compounds. The crude residue
was subjected to column chromatography (3 cm × 20 cm, silica gel
(0.063–0.200 mm,  Merck 7734)) with 20% ethyl acetate in hex-
ane as a mobile phase. The sub-fractions were pooled together to
obtain two  main fractions as monitored by thin-layer chromatog-
raphy. The ﬁrst fraction was subjected to preparative thin-layer
chromatography (pTLC) with 50% ethyl acetate/hexane to obtain
compound 1. The second fraction was also applied to pTLC with
dichloromethane (triple run) as a mobile phase to obtain com-
pound 2. Each pure compound was dissolved in 99.98% CDCl3 or in
99.8% methanol-d4 (ca.  5 mg  in 0.7 ml)  and transferred into 5 mm
NMR  sample tube (Promochem, Wesel, Germany). Spectra were
recorded by the Bruker Topspin software on a Bruker AVANCE 400
spectrometer (Bruker, Rheinstetten, Germany).
Biological assay
Determination of contents of total phenolic compounds
Total phenolic content was determined using Folin–Ciocalteu
reagent following method described by Vongsak et al. (2013b).
Each sample (1000 g/ml), 200 l was  mixed with 500 l of the
Folin–Ciocalteu reagent (diluted 1:10 with deionized water) and
800 l of sodium bicarbonate solution (7.5%, w/v). The mixture
was allowed to stand at room temperature for 30 min with inter-
mittent shaking. The absorbance was  measured at 765 nm using a
UV–Visible spectrophotometer (Hitachi®, Japan). The same proce-
dure was repeated for the gallic acid standard solution (500, 250,
125, 62.5, 31.25 and 0 g/ml) and the quantiﬁcation was  made
based on a standard curve generated with of gallic acid. The content
of total phenolic compounds was calculated as mean ± SD (n = 3)
and expressed as grams of gallic acid equivalents (GAE) in 100 g of
the extract.
Alpha glucosidase inhibition assay
The -glucosidase inhibitory activity was  carried out spec-
trophotometrically using pNPG as substrate (Zhou et al., 2015).
Samples, standard solutions (gamma- and alpha-mangostin) or
positive control (acarbose) with different concentrations (50 l,
Tables 1 and 3), -glucosidase (50 l, 2 unit/ml) and phosphate
buffer (50 l, pH 7.0) were mixed and pre-incubated at 37 ◦C
for 10 min, and then pNPG (50 l, 20 mM)  was added to start
the reaction. After incubation at 37 ◦C for 30 min, the absorbance
was measured at 405 nm using UV–Visible microplate reader
(Metertech®, Taiwan). The percent inhibition of -glucosidase
activity was  calculated as follows:
Inhibition (%) = (A1 − A2)
A1
× 100,
where A1 is the absorbance of control, and A2 is the absorbance
of samples. The extent of inhibition was  expressed as mean ± SD
(n = 3) of the enzymatic activity (IC50).
Ferric reducing antioxidant power (FRAP) assay
The FRAP assay was carried out by the method of Al-Mansoubet al. (2014). Brieﬂy, 150 l FRAP working solution (300 mM acetate
buffer, pH 3.6, 10 mM TPTZ in 40 mM HCl and 20 mM FeCl3 in a ratio
of 10:1:1) was  added to 50 l test samples. The reaction mixtures
were incubated at 37 ◦C for 8 min; the absorbance was measured at
a de Farmacognosia 25 (2015) 445–450 447
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00 nm using UV–Visible microplate reader (Metertech®, Taiwan).
errous sulfate (FeSO4·7H2O, 2.0, 1.0, 0.5, 0.25, 0.125, 0.063 mM)
as used as reference standard and the results were expressed as
mol  Fe2+ equivalent/g extract. Standard solutions (gamma- and
lpha-mangostin) and positive control (ascorbic acid) were treated
nder the same condition as the samples, and then mean ± SD
n = 3) was calculated.
BTS radical scavenging assay
ABTS radical scavenging activity was measured by the method
escribed by Al-Mansoub et al., 2014. ABTS radical cation (ABTS•+)
olution was prepared by mixing 14 mM ABTS and 4.9 mM potas-
ium persulfate solutions in equal volume. The solution was
llowed to react in the dark at room temperature for 16–20 h before
se. Then, 1 ml  of the solution was diluted with 40 ml  ethanol to
ield working ABTS solution with an absorbance of 0.70 ± 0.02 at
34 nm.  To 750 l ABTS working solution, 750 l test samples were
dded. The absorbance of each solution was determined at 734 nm
sing UV–Visible spectrophotometer (Hitachi®, Japan) after 6 min.
he corresponding blank readings were also taken and percent
nhibition was then calculated as follows:
nhibition (%) = (A1 − A2)
A1
× 100,
here A1 is the absorbance of control, and A2 is the absorbance of
amples. Each determination was done in triplicate, and the aver-
ge IC50 value was calculated as mean ± SD. Standard solutions
gamma- and alpha-mangostin) and positive control (ascorbic acid)
ere treated under the same conditions as the samples.
PPH-scavenging assay
The free radical scavenging activity of the extracts, stan-
ard solutions (gamma- and alpha-mangostin) and positive
ontrol (ascorbic acid) was investigated using 1,1-diphenyl-2-
icrylhydrazyl (DPPH) radical scavenging method (Vongsak et al.,
013b). A total of 750 l of the extract or standard/positive con-
rol was added to 750 l of DPPH in methanol solution (152 M).
fter incubation at 37 ◦C for 20 min, the absorbance of each solution
as determined at 517 nm using UV–Visible spectrophotometer
Hitachi®, Japan). The corresponding blank readings were also
aken and percent inhibition was then calculated as follows:
nhibition (%) = (A1 − A2)
A1
× 100,
here A1 is the absorbance of control, and A2 is the absorbance of
amples. Each determination was done in triplicate, and the average
C50 value was  calculated as mean ± SD.
etermination of bioactive constituent contents
The propolis extract with the highest activity was selected for
nvestigating the quantity of bioactive compounds using validated
PLC method (Vongsak et al., 2014). The instrument used was an
gilent 1260 Series® (Agilent Technologies) equipped with a 1260
uat pump VL quaternary pump, 1260 ALS autosampler, 1260 TCC
olumn thermostat, and 1260 DAD VL diode array detector. The
hromatographic separation was carried out on a Hypersil BDS®
18 column (4.6 mm × 100 mm i.d., 3.5 m)  with a C18 guard col-
mn. The mobile phases were (A) 0.2% formic acid in water and (B)
ethanol. Gradient elution was used: 75% B in A to 90% B in A for
0 min; 90% B in A to 100% B for 5 min; 100% B for 10 min. The col-
mn  was re-equilibrated with 75% B in A for 10 min  prior to each
nalysis. The ﬂow rate was 1.0 ml/min at 25 ◦C. UV–Vis detector
as monitored at the wavelength of 245 nm and injection volume
as 5 l for all samples and standards.
T. pagdeni sample was prepared by accurately weighing 30 mg
f extract and dissolving in methanol (5 ml). To enable complete Ta
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Table 2
NMR  data for compounds 1 and 2.
Compounds 1H NMR 13C NMR
Gamma-mangostin (1) (400 MHz, CDCl3/methanol-d4), ı (ppm) = 6.65 (s, 1H, ArH),
6.20 (s, 1H, ArH), 5.28–5.23 (m,  2H, vinylic-H × 2), 4.13 (d,
J  = 6.61 Hz, 2H, allylic-H), 3.34 (d, J = 7.06 Hz, 2H, allylic-H),
1.82 (s, 3H, CH3), 1.78 (s, 3H, CH3), 1.66 (s, 2 × 3H, 2 × CH3)
(100 MHz, CDCl3/methanol-d4), ı (ppm) = 182.3 (C O),
161.4 (ArC-OAr), 160.3 (ArC-OH), 154.9 (ArC-OAr), 152.9
(ArC-OH), 150.6 (ArC-OH), 139.9 (ArC-OH, 132.4 (ArC),
132.3 [CH C(CH3)2], 128.1 [CH C(CH3)2], 122.8 (CH C),
122.3 (CH C), 111.6 (ArC), 109.6 (ArC), 103.4 (ArC), 100.2
(ArCH), 92.3 (ArCH), 25.7 (2 × CH3), 25.6 (CH2), 21.3 (CH2),
17.9 (CH3), 17.6 (CH3)
Alpha-mangostin (2) (400 MHz, CDCl3), ı (ppm) = 13.80 (s, 1H, OH), 6.86 (s, 1H,
ArH),  6.32 (s, 1H, ArH), 6.28 (s, 1H, OH), 6.11 (s, 1H, OH),
5.34–5.28 (m,  2H, vinylic-H × 2), 4.12 (d, J = 6.20 Hz, 2H,
allylic-H), 3.83 (s, 3H, OCH3), 3.48 (d, J = 7.12 Hz, 2H,
allylic-H), 1.87 (s, 3H, CH3), 1.86 (s, 3H, CH3), 1.80 (s, 3H,
(100 MHz, CDCl3), ı (ppm) = 182.1 (C O),  161.6 (ArC-OAr),
160.7 (ArC-OH), 155.8 (ArC-OAr), 155.1 (ArC-OH), 154.5
(ArC-OH), 142.6 (ArC-OCH3), 137.1 (ArC), 135.7
[CH C(CH3)2], 132.1 [CH C(CH3)2], 123.2 (CH C), 121.4
(CH C), 112.3 (ArC), 108.4 (ArC), 103.7 (ArC), 101.5 (ArCH),
d
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1CH3), 1.72 (s, 3H, CH3)
issolution, each sample was sonicated for 60 min. Prior to the
njection, each solution was  ﬁltered through a 0.22 m nylon mem-
rane ﬁlter.
Stock solutions of standard compounds (1) and (2) were pre-
ared by accurately weighing and dissolving the compounds in
ethanol to obtain the ﬁnal concentration of 1000 g/ml. Work-
ng solutions of standard compounds were obtained by diluting
he stock standard solutions with methanol to achieve the desired
oncentrations. Calibration curves were constructed from the peak
rea versus the amount of the standards by least square regres-
ion across the range of 0.78–100 g/ml for compounds (1) and
.5–1000 g/ml for compound (2).
tatistical analysis
The results were reported as mean ± standard deviation (SD)
n = 3). The average contents of total phenolics, FRAP values and
C50 of the different propolis bee species extract were statistically
nvestigated using one-way analysis of variance (ANOVA) with least
igniﬁcant difference (LSD) by SPSS for Windows® 16.0. A statis-
ical probability (p value) less than 0.05 indicated a statistically
igniﬁcant difference between groups.
esults and discussion
Phenolic compounds are the principal bioactive materials in
ropolis which have been reported to have numerous pharmaco-
ogical effects, including anti-oxidation and anti-diabetes (Matsui
t al., 2004). Total phenolic contents in various stingless bees
ropolis extracts are presented in Table 1. T. pagdeni propolis
xtract promoted signiﬁcantly higher content of total phenolics
han propolis extract of other species. Total phenolics in these
ifferent propolis extracts ranged from 2.16 to 12.83 g GAE/100 g
xtract. The results indicated the possible inﬂuences of diverse stin-
less bee species on different contents of phenolics in propolis. The
lpha glucosidase inhibitory effect of various propolis extracts is
able 3
he contents of bioactive compounds and their biological activities in Tetragonula pagden
Bioactive compounds Contents of major
compounds in 80%
ethanolic extracts (% w/w)*
Alpha glucosidase
inhibitory assay
IC50 (M)*
Gamma-mangostin (1) 0.94 ± 0.01 4.22 ± 0.58a
alPha-mangostin (2) 2.77 ± 0.08 29.27 ± 7.02c
issimilar letters in the same column indicate signiﬁcantly different for each parameter at p
LSD).
* Expressed as mean ± SD (n = 3), n.d. = not detectable. In alpha glucosidase inhibitory a
nd  0 g/ml, while alpha-mangostin (2) were 100, 50, 25, 12.5, 6.25 and 0 g/ml. In ABT
00,  50, 25, 12.5, 6.25 and 0 g/ml. The concentrations for FRAP assay of gamma-mangos93.3 (ArCH), 62.0 (OCH3), 26.6 (CH2), 25.8 (CH3), 25.7
(CH3), 21.5 (CH2), 18.2 (CH3), 17.9 (CH3)
displayed in Table 1. The IC50 values of propolis extracts ranged
from 70.79 to 469.66 g/ml against baker’s yeast alpha glucosi-
dase, and that of T. pagdeni propolis extract was  signiﬁcantly lower
than 155.82 g/ml of acarbose, a positive control. Thus, T. pagdeni
propolis extract possessed the highest inhibitory effect on alpha
glucosidase compared to the other species and positive reference.
This effect was possibly due to phytochemicals, which include phe-
nolic compounds such as xanthones and phenolic acids (Ryu et al.,
2011).
Free radicals can be deleterious to cells and lead to various
chronic diseases such as diabetes, arthritis, and asthma (Vongsak
et al., 2013a). The free radical scavenging activity of stingless bees
propolis extracts was determined on the basis of the scaveng-
ing activity of FRAP, ABTS and DPPH assays (Table 1). The results
showed that the extracts possessed reducing activity in the range
of 61.14–279.70 mol  FeSO4 equivalent/g extract while that of
ascorbic acid was  7698.02 mol FeSO4 equivalent/g extract. The
extracts were able to scavenge ABTS and DPPH radical, especially
that of T. pagdeni propolis. It promoted stronger ABTS and DPPH
radical scavenging activity than the other extracts with IC50 of
59.52 and 122.71 g/ml, respectively, while ascorbic acid, a pos-
itive reference, showed the activity at IC50 of 6.07 and 7.33 g/ml,
respectively. These experiments indicated that alpha glucosidase
inhibition and free-radical scavenging activity of propolis extracts
from T. pagdeni exhibited stronger activity than that of L. ventralis
and L. terminata. Thus, T. pagdeni propolis extract was selected to
identify and quantify the bioactive compounds.
Gamma-mangostin (1) and alpha-mangostin (2) were separated
and identiﬁed as the active constituents in T. pagdeni propolis
extract from mangosteen orchard (Table 2). In alpha glucosidase
inhibition assay, each compound demonstrated noteworthy alpha
glucosidase inhibitory effect (IC50 4.22 and 29.27 M)  while acar-
bose displayed the IC50 of 241.36 M (Table 3). These chemicals
were previously reported in seedcases of Garcinia mangostana and
had been reported to display alpha glucosidase inhibitory effect
(Ryu et al., 2011). In regards to free radical scavenging activity,
i propolis extract from mangosteen orchard.
FRAP assay (mol FeSO4
equivalent/gram extract)*
ABTS assay
IC50 (M)*
DPPH assay
IC50 (M)*
5366.82 ± 54.71a 160.92 ± 1.23a 39.94 ± 1.16 a
15.32 ± 3.89c n.d. n.d.
 < 0.05 using one-way analysis of variance (ANOVA) with least signiﬁcant difference
ssay, the concentrations of gamma-mangostin (1) were 12.5, 6.25, 3.125, 1.56, 0.77
S assay and DPPH assay the concentrations of gamma- and alpha-mangostin were
tin and alpha-mangostin were 200 g/ml.
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Fig. 1. HPLC ﬁngerprints of Tetragonula pagdeni propolis extract from ma
amma-mangostin (1) exhibited a strong activity comparable to
hat of ascorbic acid in the DPPH assay while alpha-mangostin (2)
howed weak to non-detectable activity in ABTS and DPPH assays
Table 3).
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HPLC was used to quantify bioactive compounds, gamma- and
lpha-mangostin in the T. pagdeni propolis extract because of the
trongest activities. This method has been validated for its linear-
ty, precision, and accuracy (Vongsak et al., 2014). The amounts of
ioactive compounds, gamma-mangostin (1) and alpha-mangostin
2), in the T. pagdeni propolis extract were 0.94 and 2.77% (w/w),
espectively (Table 3) at retention times of 7.46 and 9.98 min,
espectively (Fig. 1), respectively, in the HPLC ﬁngerprints. The
resence of these mangostin derivatives is considered to be vital
or the alpha glucosidase inhibitory effect of T. pagdeni propolis.
In conclusion, the study provides data to support the usage of
ifferent stingless bee propolis cultivated in mangosteen orchard
s raw material for natural antioxidant and anti-diabetic agents.
ased on this study, the propolis extract of T. pagdeni should
e utilized as a better source of raw material for alpha glucosi-
ase inhibitory effect and anti-oxidative purposes than others.
he mangostin derivatives, especially gamma-mangostin, the most
ctive agent, could possibly be applied as markers for standardiza-
ion.
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